Profile
| Metric | Value |
|---|---|
| Full Name | Adaptimmune Therapeutics plc |
| Ticker | NASDAQ: ADAP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | adaptimmune.com |
| Employees | 506 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.03 | |
| Price, 1D Change | - | |
| $7M | ||
| - | ||
| - | ||
| 0.92 | ||
| $178M | ||
| Revenue, 1Y Change | +194.32% | |
| -$0.28 | ||
| EPS, 1Y Change | +50.61% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.28 | ||
| EPS Estimate | N/A | -$0.47 |
| EPS Est. Change | N/A | -67.74% |
| $178.11M | ||
| Revenue Estimate | N/A | $40.40M |
| Revenue Est. Change | N/A | -77.32% |
| Current Price | $0.03 | |
| Price Target | - | $0.46 |
| Price Tgt. Change | - | +1,711.02% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.44 | -$0.57 | -29.20% | |
| -$0.14 | -$0.28 | -97.75% | |
| -$0.47 | N/A | -67.74% | |
| -$0.50 | N/A | -77.35% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $80.54M | $60.51M | -24.86% | |
| $182.99M | $178.11M | -2.67% | |
| $40.40M | N/A | -77.32% | |
| $66.12M | N/A | -62.87% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.03 | |
| $0.17 | ||
| SMA 200 vs Price | +559.45% | |
| $0.05 | ||
| SMA 50 vs Price | +88.58% | |
| 0.92 | ||
| $0.01 | ||
| 32.43 | ||
| 97.47% | ||
| 210.77% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $178.11M | ||
| -$0.28 | ||
| $177.96M | ||
| 93.66% | ||
| -$63.85M | ||
| -35.85% | ||
| -$70.84M | ||
| -39.78% | ||
| -$52.62M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 6.26 | ||
| 2.92 | ||
| 2.80 | ||
| - | ||
| 0 | ||
| -5.74 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 0.10 | ||
| -0.09 | ||
| -0.20 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $11.85M | ||
| $91.14M | ||
| $245.96M | ||
| $188.17M | ||
| $234.11M | ||
| $64.53M | ||
| $74.21M | ||
| $4.71M | ||
| $8.69M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $248.95M | ||
| $230.66M | ||
| $11.30M | ||
| $87.30M | ||
| $11.23M | ||
| $0.00 | ||
| -$7.89M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$73.24M | ||
| -$58.98M | ||
| $78.78M | ||
| $2.72M | ||
| -$75.96M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Mizuho | → | |
| Wells Fargo | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Wells Fargo | → | |
| Scotiabank | → | |
| Mizuho | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ADAP
FAQ
What is the ticker symbol for Adaptimmune Therapeutics plc?
The ticker symbol for Adaptimmune Therapeutics plc is NASDAQ:ADAP
Does Adaptimmune Therapeutics plc pay dividends?
No, Adaptimmune Therapeutics plc does not pay dividends
What sector is Adaptimmune Therapeutics plc in?
Adaptimmune Therapeutics plc is in the Healthcare sector
What industry is Adaptimmune Therapeutics plc in?
Adaptimmune Therapeutics plc is in the Biotechnology industry
What country is Adaptimmune Therapeutics plc based in?
Adaptimmune Therapeutics plc is headquartered in United Kingdom
When did Adaptimmune Therapeutics plc go public?
Adaptimmune Therapeutics plc initial public offering (IPO) was on May 6, 2015
Is Adaptimmune Therapeutics plc in the S&P 500?
No, Adaptimmune Therapeutics plc is not included in the S&P 500 index
Is Adaptimmune Therapeutics plc in the NASDAQ 100?
No, Adaptimmune Therapeutics plc is not included in the NASDAQ 100 index
Is Adaptimmune Therapeutics plc in the Dow Jones?
No, Adaptimmune Therapeutics plc is not included in the Dow Jones index
When was Adaptimmune Therapeutics plc last earnings report?
Adaptimmune Therapeutics plc's most recent earnings report was on November 12, 2025
When does Adaptimmune Therapeutics plc report earnings?
The date for Adaptimmune Therapeutics plc's next earnings report has not been announced yet
Data Sources & References
- ADAP Official Website www.adaptimmune.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1621227/000155837025011307/0001558370-25-011307-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1621227/000155837025003544/0001558370-25-003544-index.htm
- ADAP Profile on Yahoo Finance finance.yahoo.com/quote/ADAP
- ADAP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/adap